Primo Chemicals Ltd

  • BSE Code : 506852
  • NSE Symbol : PRIMO
  • ISIN : INE607A01022
  • Industry :CHLOR ALKALI / SODA ASH

up-arrow 21.42 2.27(11.85%)

Open Price ()

19.48

Prev. Close ()

19.15

Volume (No’s)

366,200

Market Cap ()

519.10

Low Price ()

19.12

High Price ()

22.00

 

Board Meetings

Start Date End Date Purpose
02-Feb-2026 12-Feb-2026 Primo Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve Attached. Board Meeting Outcome for Unaudited Financial Results (Standalone & Consolidated) For Quarter And Nine Months Ended 31.12.2025 (As per BSE Announcement dated on: 12.02.2026)
03-Nov-2025 14-Nov-2025 Primo Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Unaudited Financial Results (Standalone & Consolidated) for quarter and half year ended 30.09.2025. Unaudited Financial Results (Standalone & Consolidated) For Quarter And Half Year Ended 30.09.2025. Outcome of Board Meeting (As per BSE Announcement dated on: 14.11.2025)
04-Aug-2025 14-Aug-2025 Primo Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve the Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended 30 June 2025. Attached. (As Per BSE Announcement Dated on: 14/08/2025
19-May-2025 30-May-2025 Primo Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve Audited Financial Results (Standalone & Consolidated) for the Quarter and Year ended 31st March 2025. Pursuant to the Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith ''Audited Financial Results (Standalone and Consolidated) for the Quarter and Year ended 31st March, 2025'' alongwith Auditors Report thereon and Declaration regarding Audit Report with unmodified opinion approved by Board of Directors of the Company at its meeting held on 30th May, 2025 commenced at 12:30 Hours and concluded at 15:45 Hours Attached. (As Per BSE Announcement dated on 30.05.2025)
01-Feb-2025 14-Feb-2025 Primo Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve Unaudited Financial Results (Standalone & Consolidated) For the Quarter and Nine Months ended 31st December 2024. Pursuant to the Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company in its meeting held on 14' February, 2025, commenced at 12:30 Hours and concluded at 14:00 Hours, inter-alia, has considered and approved the following: 1. Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended 31 December, 2024 alongwith Limited Review Reports issued by Statutory Auditors; and 2. Shifting of the Registered Office of the Company within local limits of the City from S.C.O. 125-127, Sector 17-B, Chandigarh- 160017 to Corporate Office of the Company at Bay No. 46-50, Sector 31A, Chandigarh- 160030 w.e.f. 01.03.2025. Attached. (As Per BSE Announcement Dated on 14.02.2025) Attached. (As per BSE Announcement Dated on 15/02/2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew